Silo pharma reports third quarter results and operating highlights

Englewood cliffs, nj, nov. 11, 2021 (globe newswire) -- silo pharma, inc. (otcqb: silo), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today reported its financial results for the third quarter 2021 and gave an update on recent progress in its business.
SILO Ratings Summary
SILO Quant Ranking